(Q39443098)

12 September 2017

title

Fusion of HSA influences TNF-α neutralizing activity of shTNFRs (English)

1 reference

12 September 2017

0 references

Jia Zhan

1

1 reference

12 September 2017

Ying Chen

2

1 reference

12 September 2017

Han-Ying Yuan

3

1 reference

12 September 2017

Hai Li

4

1 reference

12 September 2017

Hong Lu

5

1 reference

12 September 2017

publication date

15 November 2011

1 reference

12 September 2017

published in

Biotechnology Letters

1 reference

12 September 2017

volume

34

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

417-423

1 reference

Aggressive cutaneous T-cell lymphomas after TNFalpha blockade

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10529-011-0793-3

Heterologous protein expression in the methylotrophic yeast Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-011-0793-3

Expression in Pichia pastoris and properties of human serum albumin-interferon alpha2b chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-011-0793-3

Pharmaceutical strategies utilizing recombinant human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-011-0793-3

Recent advances in the expression of foreign genes in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-011-0793-3

The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-011-0793-3

Summary of recombinant human serum albumin development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-011-0793-3

Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-011-0793-3

An IFN-beta-albumin fusion protein that displays improved pharmacokinetic and pharmacodynamic properties in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-011-0793-3

Tumor necrosis factor family ligand-receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-011-0793-3

Circumventing the heterogeneity and instability of human serum albumin-interferon-alpha2b fusion protein by altering its orientation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-011-0793-3

10.1007/S10529-011-0793-3

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference